Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionIeq Capital, Llc
Latest Disclosed Ownership17,747 shares
Latest Disclosed Value $ 2,473,406
Ieq Capital, Llc reports 85.45% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Ieq Capital, Llc filed a 13F-HR form disclosing ownership of 17,747 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,473,406 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 121,947 shares of Gilead Sciences, Inc.. This represents a change in shares of -85.45% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 17,747 -104,200 -85.45 2,473 -83.48 0.0083
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 121,947 11,133 10.05 14,968 21.68 0.0448
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 110,814 -7,881 -6.64 12,300 -6.53 0.0373
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 118,695 12,705 11.99 13,160 10.80 0.0805
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 105,990 39,330 59.00 11,876 92.89 0.0945
2025-02-03 2024-12-31 13F GILEAD SCIENCES COM 375558103 66,660 -15,591 -18.96 6,157 -10.70 0.0595
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 82,251 13,036 18.83 6,896 45.22 0.0846
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 69,215 2,453 3.67 4,749 -2.90 0.0639
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 66,762 -2,153 -3.12 4,890 -12.40 0.0703
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 68,915 8,220 13.54 5,583 22.74 0.0929
2023-11-06 2023-09-30 13F GILEAD SCIENCES COM 375558103 60,695 933 1.56 4,549 -1.24 0.0925
2023-08-08 2023-06-30 13F GILEAD SCIENCES COM 375558103 59,762 1,788 3.08 4,606 -4.26 0.0929
2023-05-02 2023-03-31 13F GILEAD SCIENCES COM 375558103 57,974 -3,875 -6.27 4,810 -9.40 0.1115
2023-02-06 2022-12-31 13F GILEAD SCIENCES COM 375558103 61,849 4,954 8.71 5,310 51.25 0.1487
2022-11-04 2022-09-30 13F GILEAD SCIENCES COM 375558103 56,895 11,118 24.29 3,510 24.03 0.0963
2022-07-27 2022-06-30 13F GILEAD SCIENCES COM 375558103 45,777 -1,934 -4.05 2,830 -0.21 0.0857
2022-04-26 2022-03-31 13F GILEAD SCIENCES COM 375558103 47,711 -9,629 -16.79 2,836 -31.88 0.0676
2022-01-31 2021-12-31 13F GILEAD SCIENCES COM 375558103 57,340 1,499 2.68 4,163 6.72 0.0963
2021-11-09 2021-09-30 13F GILEAD SCIENCES COM 375558103 55,841 15,108 37.09 3,901 39.07 0.1036
2021-07-29 2021-06-30 13F GILEAD SCIENCES COM 375558103 40,733 17,718 76.98 2,805 88.63 0.0824
2021-05-04 2021-03-31 13F GILEAD SCIENCES COM 375558103 23,015 5,693 32.87 1,487 47.37 0.0614
2021-02-03 2020-12-31 13F GILEAD SCIENCES COM 375558103 17,322 -4,588 -20.94 1,009 -27.10 0.0449
2020-11-03 2020-09-30 13F GILEAD SCIENCES COM 375558103 21,910 4,905 28.84 1,384 5.73 0.0744
2020-07-31 2020-06-30 13F GILEAD SCIENCES COM 375558103 17,005 2,985 21.29 1,309 24.79 0.0850
2020-05-07 2020-03-31 13F GILEAD SCIENCES COM 375558103 14,020 5,423 63.08 1,049 87.99 0.0842
2020-02-11 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 8,597 8,597 558 0.0489
2020-02-04 2019-12-31 13F GILEAD SCIENCES COM 375558103 10,278 359
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.